Delphi Genetics Overview
- Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
32
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50M
Delphi Genetics General Information
Description
Developer of molecular tools designed to offer deoxyribonucleic acid engineering services. The company's tool is used for synthetic biology, allowing successful cloning of genes and expression of recombinant proteins at a higher yield, enabling researchers to significantly increase the stability of plasmid DNA in host strains, resulting in overall production yield and reproducibility improvement.
Contact Information
Primary Industry
Biotechnology
Acquirer
Primary Office
- Rue A. de Saint-Exupéry, 5
- 6041 Charleroi
- Belgium
Delphi Genetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 25-Feb-2021 | $50M | 00.000 | 0000 | Completed | Generating Revenue |
| 2. Debt - General | 28-Jun-2016 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 1. Later Stage VC | 10-Mar-2015 | $1.12M | $1.12M | Completed | Generating Revenue |
Delphi Genetics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Delphi Genetics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 50 North Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Invest4 DelphiG2 | Other | Minority | 000 0000 | 000000 0 | |
| Michel Milinkovitch | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| SambrInvest | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Université Libre de Bruxelles | University | Minority | 000 0000 | 000000 0 |